We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.75B
1-Year Est. Return 46.53%
This Fund
S&P 500
This Quarter Est. Return
+2.59%
1 Year Est. Return
+46.53%
3 Year Est. Return
+120.27%
5 Year Est. Return
+150.66%
10 Year Est. Return
+646.21%
AUM
$2.91B
AUM Growth
-$2.79M
Cap. Flow
-$27.2M
Cap. Flow %
-0.93%
Top 10 Hldgs %
20.73%
Holding
3,310
New
248
Increased
388
Reduced
954
Closed
189

Top Buys

Rank Stock Value
1
FPE icon
First Trust Preferred Securities and Income ETF
FPE
+$6.56M
2
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$3.36M
3
ILMN icon
Illumina
ILMN
+$3.21M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$3M
5
RBA icon
RB Global
RBA
+$2.93M

Top Sells

Rank Stock Value
1
PFFD icon
Global X US Preferred ETF
PFFD
+$5.94M
2
VST icon
Vistra
VST
+$5.92M
3
GDDY icon
GoDaddy
GDDY
+$5M
4
SMCI icon
Super Micro Computer
SMCI
+$4.37M
5
IVW icon
iShares S&P 500 Growth ETF
IVW
+$4M

Sector Composition

Rank Sector Weight
1 Technology 21.86%
2 Industrials 10.11%
3 Consumer Discretionary 9.49%
4 Financials 8.92%
5 Healthcare 8.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZYME icon
2151
Zymeworks
ZYME
$1.77B
$47.8K ﹤0.01%
5,616
– –
AMAL icon
2152
Amalgamated Financial
AMAL
$1.53B
$47.8K ﹤0.01%
1,744
– –
SEMR
2153
DELISTED
Semrush
SEMR
$47.6K ﹤0.01%
3,554
+966
+37% +$13.4K
MCBS icon
2154
MetroCity Bankshares
MCBS
$1.04B
$47.6K ﹤0.01%
1,802
– –
LASR icon
2155
nLIGHT
LASR
$2.9B
$47.5K ﹤0.01%
4,350
– –
NXDR
2156
Nextdoor Holdings
NXDR
$986M
$47.5K ﹤0.01%
17,089
+5,069
+42% +$11.7K
CCRN
2157
DELISTED
Cross Country Healthcare
CCRN
$47.3K ﹤0.01%
3,421
– –
URGN icon
2158
UroGen Pharma
URGN
$2.34B
$47.3K ﹤0.01%
2,816
– –
AVO icon
2159
Mission Produce
AVO
$1.13B
$47.2K ﹤0.01%
4,781
– –
RGNX icon
2160
Regenxbio
RGNX
$704M
$47.2K ﹤0.01%
4,037
– –
STOK icon
2161
Stoke Therapeutics
STOK
$2.02B
$47.1K ﹤0.01%
3,484
+1,206
+53% +$16.3K
MITK icon
2162
Mitek Systems
MITK
$853M
$47.1K ﹤0.01%
4,210
– –
FOX icon
2163
Fox Class B
FOX
$24.4B
$46.9K ﹤0.01%
1,466
– –
PTVE
2164
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
$46.9K ﹤0.01%
4,146
– –
EEM icon
2165
iShares MSCI Emerging Markets ETF
EEM
$30.5B
$46.8K ﹤0.01%
1,100
– –
SNCY
2166
DELISTED
Sun Country Airlines
SNCY
$46.7K ﹤0.01%
3,720
– –
ZIMV
2167
DELISTED
ZimVie
ZIMV
$46.6K ﹤0.01%
2,552
+3
+0.1% +$49
STER
2168
DELISTED
Sterling Check Corp. Common Stock
STER
$46.6K ﹤0.01%
3,146
– –
NBN icon
2169
Northeast Bank
NBN
$1.16B
$46.6K ﹤0.01%
765
– –
CHUY
2170
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
$46.5K ﹤0.01%
1,795
– –
CAC icon
2171
Camden National
CAC
$990M
$46.5K ﹤0.01%
1,409
– –
EVER icon
2172
EverQuote
EVER
$867M
$46.4K ﹤0.01%
2,223
– –
OFIX icon
2173
Orthofix Medical
OFIX
$415M
$46.3K ﹤0.01%
3,494
– –
CLBK icon
2174
Columbia Financial
CLBK
$1.21B
$46K ﹤0.01%
3,075
– –
CATX icon
2175
Perspective Therapeutics
CATX
$372M
$46K ﹤0.01%
+4,613
New +$66.7K
85 86
87
88 89

Similar funds

DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
GCC
Guardian Capital (Canada) Toronto, Ontario, Canada $3.78B AUM 33.04% 1-Year Est. Return
SB
SIG Brokerage New York $3.79B AUM 44.46% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return
CI
Cavalier Investments Alpharetta, Georgia $3.7B AUM 51.42% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return

Ameritas Investment Partners's Q2 2024 Portfolio in Review

As of Q2 2024, Ameritas Investment Partners held 3,310 positions worth $2.91B, down 0.1% from $2.92B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Ameritas Investment Partners's Q2 2024 filing shows 248 new, 388 increased, 954 reduced and 189 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 40,387 shares worth $3.33M. The largest sale was Global X US Preferred ETF, an estimated $5.94M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Ameritas Investment Partners's largest Q2 2024 buy was BioMarin Pharmaceuticals: 40,387 shares worth $3.33M.
  • Ameritas Investment Partners added most to First Trust Preferred Securities and Income ETF in Q2 2024, an estimated $6.56M increase.
  • Ameritas Investment Partners's biggest Q2 2024 reduction was Global X US Preferred ETF, cutting an estimated $5.94M.
  • Ameritas Investment Partners fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $2.65M.
  • Ameritas Investment Partners's ten largest holdings make up 21% of its $2.91B portfolio in Q2 2024.
  • Ameritas Investment Partners opened 248 new positions and closed 189 in Q2 2024.
  • Ameritas Investment Partners's portfolio value fell 0.1% quarter-over-quarter to $2.91B.

Based on Ameritas Investment Partners's 13F filing for Q2 2024, filed 13 Aug 2024.